Skip to main content

Nonprofit · EIN 77-0720482

CALIFORNIA BIOTECHNOLOGY FOUNDATION

Tax-exempt · SACRAMENTO, CA 95814

Financials

$773K$765K2023$655K$739K2024
Revenue Expenses · by fiscal year end
Financials of CALIFORNIA BIOTECHNOLOGY FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$655,214$738,709-$83,495-$35,094$0-$35,094
December 31, 2023990$773,002$765,262$7,740$48,401$0$48,401
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$655,214
Membership dues
$415,000
Program service revenue
$0
Investment income
$0
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$155,273
Other salaries and wages
$28,660
Salaries, compensation and benefits (total)
$245,667
Professional fundraising fees
$0
Legal fees
$85
Occupancy
$10,923
Program services (functional)
$590,966
Management and general (functional)
$147,743

Balance sheet and other

Total assets, start of year
$48,401
Total assets, end of year
-$35,094
Total liabilities, end of year
$0
Net assets, end of year
-$35,094
Net assets without donor restrictions
-$35,094
Gross receipts
$655,214
Employees
0
Year formed
2008
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Patricia CooperTreasurer
Trustee or director, Officer
40$155,273$51,799
Amanda BanksSecretary
Trustee or director, Officer
1$0$0
Joseph PanettaChairman
Trustee or director, Officer
1$0$0
990 for the year ended December 31, 2023: 3 people
NameTitleHours / weekCompensationOther / benefits
PATRICIA COOPERTREASURER
Trustee or director, Officer
40$122,632$35,521
AMANDA BANKSSECRETARY
Trustee or director, Officer
1$0$0
JOSEPH PANETTACHAIRMAN
Trustee or director, Officer
1$0$0

Address and contacts

Address (IRS master file)
1215 K ST STE 970, SACRAMENTO, CA 95814-3946
In care of
% PATRICIA COOPER
Signed the 990
Patricia Cooper, Treasurer
Phone
(916) 233-3499
Return prepared by
Sacramento Accounting & Advisory Group LLP

Mission

The primary objectives and purposes of corporation shall be to educate the public concerning biotechnology and healthcare - related fields

990 for the year ended December 31, 2024

Program accomplishments

  • EXPLANATIONHIGHLIGHT LIFE SCIENCE INDUSTRYS EFFORTS ON COMBATING COVID-19 AND OTHER ILLNESSES * CBF CONTINUED PUBLISHING WEEKLY COVID-19 UPDATE NEWSLETTER IN 2022 WITH EMERGING NEWS AND PERTINENT INFORMATION RELATED TO LIFE SCIENCE ADVANCEMENTS IN TESTING, TREATMENTS, AND VACCINES. * CBF USED SOCIAL MEDIA, THE WEBSITE, AND DIGITAL ADVERTISING TO SHARE UPDATES ON THE EMERGING MPOX PUBLIC HEALTH CHALLENGE. MATERIALS INCLUDED HIGHLIGHTS OF EFFORTS TO PREVENT MPOX FROM REACHING PANDEMIC STATUS. THESE EFFORTS WERE HIGHLIGHTED IN CBFS MONTHLY NEWSLETTER. * DEVELOPED COVID-19 TIMELINE FACT SHEET ON VACCINES, TESTS, TREATMENTS FOR MONTHLY NEWSLETTER. OTHER EDUCATION * OVERVIEW OF LIFE SCIENCES IN CALIFORNIA TO POLICYMAKERS AT A BRIEFING. * ENGAGED POLICYMAKERS THROUGH REGULAR EMAIL UPDATES, NEWSLETTER CONTENT AND SOCIAL MEDIA. * POSITION CBF AS THE GO-TO INFORMATIONAL RESOURCE TO LEARN MORE ABOUT CA LIFE SCIENCES * EVENT TOUR OF WA LIFE SCIENCES WITH INDUSTRY REPRESENTATIVES COLLATERAL: FACTS SHEETS, UPDATES, AND NEWSLETTERS * COVID-19 TIMELINE OF LIFE SCIENCE MEDICAL INNOVATIONS FACT SHEET: STEPS TAKEN TO COMBAT THE COVID-19 PANDEMIC AND DISPEL MISINFORMATION RELATED TO VACCINE DEVELOPMENT AND DEPLOYMENT. * LIFE SCIENCE INNOVATIONS FIGHT COVID-19 FACT SHEET: CAS ROLE IN DEVELOPING APPROACHES TO TESTING, CLINICAL TRIALS, VACCINES, AND TREATMENTS.* JAMA STUDY EXAMINES WHETHER 340B DRUG DISCOUNT PROGRAM GENUINELY SERVES VULNERABLE COMMUNITIES FACT SHEET: DEVELOPED IN RESPONSE TO A JAMA STUDY SHOWING THAT 340B BENEFITS PRIMARILY SERVED WHITE, AFFLUENT AREAS. * DMHC REPORT SHOWS HEALTH PLAN PROFIT ANDNON-MEDICAL EXPENSES FAR EXCEED RX EXPENDITURES FACT SHEET: DMHC REPORTS ON PRESCRIPTION DRUG CONSUMER EXPENDITURES. MAINTAIN STAKEHOLDER RELATIONSHIPS * BIOCOM 2021 ECONOMIC IMPACT REPORT DATABOOK INFORMATION * REGULARLY ATTENDANCE AT A VARIETY OF STAKEHOLDER MEETINGS* HIGHLIGHT STAKEHOLDERS AT EVENTS, AND IN NEWSLETTERS AND SOCIAL MEDIA * AMPLIFY THE LATEST STAKEHOLDER NEWS AND EVENTS EXECUTE SOCIAL MEDIA CAMPAIGN TO LEVERAGE FACTS AROUND LIFE SCIENCES IN CA * DESIGNED AND EXECUTED MULTIPLE SOCIAL MEDIA AND DIGITAL DISPLAY CAMPAIGNS TO EDUCATE STAKEHOLDERS. * STRATEGICALLY DEPLOYED DIGITAL TO SUPPORT PRIORITY ACTIVITIES OF THE TEAM TO BRING HISTORICALLY OFFLINE ACTIVITIES INTO A DIGITAL ENVIRONMENT. * CBF MAINTAINS A ROBUST ORGANIC SOCIAL MEDIA PRESENCE INCLUDING SHARING THE LATEST NEWS AND EVENTS FROM STAKEHOLDER AND HIGHLIGHTING HEALTHCARE STAKEHOLDERS ON SOCIAL MEDIA DURING AWARENESS MONTHS SUCH AS HISPANIC HERITAGE MONTH AND BREAST CANCER AWARENESS MONTH.
    Expenses $590,966

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
77-0720482
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2010
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$35,094
Income (IRS master file)
$655,214

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024–––IRS
990December 2023–––IRS
990December 2022$872,550$899,739$40,661IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.

Questions about CALIFORNIA BIOTECHNOLOGY FOUNDATION

What is the EIN of CALIFORNIA BIOTECHNOLOGY FOUNDATION?
The employer identification number (EIN) of CALIFORNIA BIOTECHNOLOGY FOUNDATION is 77-0720482.
Is CALIFORNIA BIOTECHNOLOGY FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2010.
Are donations to CALIFORNIA BIOTECHNOLOGY FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CALIFORNIA BIOTECHNOLOGY FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CALIFORNIA BIOTECHNOLOGY FOUNDATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CALIFORNIA BIOTECHNOLOGY FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who are the officers and directors of CALIFORNIA BIOTECHNOLOGY FOUNDATION?
The 990 for the year ended December 31, 2024 lists 3 people; 1 received compensation from the organization, the highest $155,273 (Patricia Cooper, Treasurer).
How much revenue does CALIFORNIA BIOTECHNOLOGY FOUNDATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $655,214, expenses of $738,709 and total assets of -$35,094 at year end.

Other nonprofits in SACRAMENTO

All nonprofits in SACRAMENTO · California · Science and technology